Analysts/Sadia Rahman

Sadia Rahman

Healthcare

Limited coverage. Only 1 question of coverage. Treat these numbers as directional — sample too small for reliable averages.

1

Companies

1

Questions

Focus Areas2 topics

Innovation & R&D1Competitive Dynamics1

Question History1 questions

AMGNAmgen Inc.1 quarter

2025 Q2

Can you talk about the -- your confidence in the TEZSPIRE COPD program in light of a competitor's Phase III trial missing despite good Phase II data

Innovation & R&DCompetitive DynamicsView in transcript →